WILEX AG

  • WKN: 661472
  • ISIN: DE0006614720
  • Land: Deutschland

Nachricht vom 06.07.2012 | 16:18

WILEX AG: Release according to Article 26, Section 1 of the WpHG [the German Securities Trading Act] with the objective of Europe-wide distribution


WILEX AG 

06.07.2012 16:18

Dissemination of a Voting Rights Announcement, transmitted by
DGAP - a company of EquityStory AG.
The issuer is solely responsible for the content of this announcement.
---------------------------------------------------------------------------


WILEX AG, Grillparzerstr. 10, 81675 Munich, Germany (ISIN DE0006614720, WKN
661472) has received on 3 July and 5 July 2012 the following two voting
rights announcements according to Article 21, Section 1 of the WpHG:

The Voting Rights of TVM V Life Science Ventures GmbH & Co. KG, Munich,
Germany, on WILEX AG, Munich, Germany, have exceeded the 3% threshold of
the Voting Rights on 29 June 2012 and amounted to 4.50% (this corresponds
to 1,115,606 Voting Rights).

The Voting Rights of TVM V Life Science Management GmbH & Co. KG Munich,
Germany, on WILEX AG, Munich, Germany, have exceeded the 3% threshold of
the Voting Rights on 29 June 2012 and amounted to 4.50% (this corresponds
to 1,115,606 Voting Rights). According to Article 22, Section 1, Sentence
1, No. 1 of the WpHG, these Voting Rights are to be attributed to the
company from TVM V Life Science Ventures GmbH & Co. KG, Munich, Germany.

Munich, 6 July 2012
WILEX AG
The Executive Management Board



06.07.2012 DGAP's Distribution Services include Regulatory Announcements,
Financial/Corporate News and Press Releases.
Media archive at www.dgap-medientreff.de and www.dgap.de

---------------------------------------------------------------------------
 
Language:     English
Company:      WILEX AG
              Grillparzerstr. 10
              81675 München
              Germany
Internet:     www.wilex.com
 
End of Announcement                             DGAP News-Service
 
---------------------------------------------------------------------------

Anleihe im Fokus

7,75% p.a. - Rendite aus Familienhand

– Zeichnungsstart: 23. Mai – Börse Frankfurt
– Zeichnung ab 1.000 Euro
– Laufzeit 5 Jahre
– WKN: A1TNA7
– 100% Rückzahlungskurs

GBC-Fokusbox

Syzygy AG: Aktie kaufen

Die nach den ersten drei Monaten des laufenden Jahres von Syzygy präsentierten Zahlen liegen im Rahmen unserer Erwartungen. Angesichts unserer unveränderten Prognosen behalten wir das bisherige Kursziel von 5 € bei und erneuern das Rating KAUFEN.

Aktueller Webcast

Allianz SE

Analysts' conference call on 1Q 2013

15. Mai 2013

Aktuelle Research-Studie

Orad Hi-Tec Systems Ltd

Original-Research: Orad Hi Tec Systems (von VEM Aktienbank AG): Kaufen

21. Mai 2013